Initially designed for paediatric and rare diseases, the Atom5TM platform can enhance compliance and has the potential to improve the outcomes of any clinical trial. Its data-driven, decentralised platform allows for clinical studies to be done anytime, anywhere, allowing patients and their caregivers to participate in research from the comfort of their own homes.
Our therapy areas
We’re involved in projects across many areas including Rare Disease, Paediatrics, Ataxia and Neurodegenerative conditions, and provide support for R&D of more patient-centric clinical outcomes through initiatives such as our Patient Group Accelerator Programme.
Our success stories
Our Credentials
21 CFR Part 11 compliant
Cyber Essentials Plus
ISO 13485
ISO 27001
ePrivacy App
